Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Elham1
    Junior Member
    • Dec 2013
    • 6

    Design a probe for target enrichment assay for NGS

    Hi everyone,

    I designed several probes for highly polymorphic region to do target enrichment assay. In particular region, I will have around 200-300 different probes that are just different in one nucleotide to distinguish different alleles. I am unsure having probes with one or two nucleotides different will be affecting the enrichment assay to run in Miseq. Can anyone help me?

    Thanks.
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    I assume probes are being used for one of in solution capture kits or a similar homebrew. The probes does not need to be exact match of target region. One or two differences in base sequences is less likely to affect your assay. The whole idea of capture is to obtain homologous region sequences which are divergent. Standard hybridisation conditions is able to capture sequences with at least 80% similarity. Altering hybridisation and washing temperature is one of the ways to change stringency. By using low stringent conditions capturing sequencing down to 70% homology is possible with the expense of increased off target capture.

    Comment

    • Elham1
      Junior Member
      • Dec 2013
      • 6

      #3
      Hi

      Thank you for response but I actually meant that whether or not these closely matching probes adversely affect the enrichment?

      Comment

      • nucacidhunter
        Jafar Jabbari
        • Jan 2013
        • 1250

        #4
        If they are used for in solution hybrid capture reaction to pull out homologous fragments for sequencing, closely matching probes will not have any nagative impact. Probes should be cross checked to ensure that they are not complemntary, otherwise thay will hybridise to each other not to target library fragments.

        Comment

        • GW_OK
          Senior Member
          • Sep 2009
          • 411

          #5
          Why not just have one (or a few) probes to the same site, if they're only differing by 1 base? This is what I think nucacidhunter was referring to.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          31 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          23 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          214 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          79 views
          0 reactions
          Last Post SEQadmin2  
          Working...